- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06192095
Applying Liquid Skin Barrier Film to Prevent Skin Complications Around Indwelling Vascular Catheters in Pediatric Patients: a Randomized Controlled Trial
January 17, 2025 updated by: National Taiwan University Clinical Trial Center, National Taiwan University Hospital
Long-term indwelling vascular catheters including central venous catheters, peripherally inserted central venous catheters, arterial catheters are often essential for medical care.
During the routine care, some patients may experience skin damage around the catheter insertion site due to allergic reactions to the catheter dressing material, physical damage during dressing changes, leading to infection, prolonged hospitalization, and unexpected medical costs.
If the condition is mild, it may increase the number of dressing changes.
In severe cases, it may require changing to a different dressing method, using medication, or even removing the indwelling catheter.
This study investigates the efficacy of liquid skin barrier film in preventing skin damage around long-term indwelling vascular catheters.
In this randomized controlled trial, the participants aged 0 to less than 18 years who has long-term indwelling vascular catheters inserted at National Taiwan University Hospital Yunlin Branch will be recruited.
At the time of indwelling vascular catheter insertion, the subjects are randomly assigned to the control group or the experimental group.
The control group received standard care according to the hospital's guidelines, using a sterile transparent dressing or gauze to cover the catheter insertion site.
The experimental group first applied liquid skin barrier film to the skin, then applied a sterile transparent dressing or gauze to cover the catheter insertion site.
The patients are followed for two weeks.
The primary endpoint is the need for change of dressing, use of medication, or removal of the catheter due to skin damage around the catheter insertion site.
The secondary endpoints are skin breakdown, number of dressing changes, and incidence of bloodstream infection.
It is expected that the research results may change the standard clinical management of long-term indwelling vascular catheters.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
120
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Yunlin
-
Douliu, Yunlin, Taiwan, 640
- National Taiwan University Hospital Yunlin Branch
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Child
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- Age 0-17 years (less than 18 years old)
- Receiving a central venous catheter, peripherally inserted central catheter, or arterial line insertion
Exclusion Criteria:
- The skin around the catheter insertion site is not inact
- Known allergic to liquid skin barrier film
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
No Intervention: Without skin barrier film
Routine care without skin barrier film around the insertion site of a vascular indwelling catheter
|
|
|
Experimental: With skin barrier film
Routine care with preventive use of skin barrier film around the insertion site of a vascular indwelling catheter
|
Preventive use of skin barrier film after insertion of a vascular indwelling catheter before covering with transparent dressing +/- gauze
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change of dressing method
Time Frame: 0-14 days
|
Change of dressing method due to injury/allergy of skin around the vascular indwelling catheters
|
0-14 days
|
|
Medical treatment for the skin
Time Frame: 0-14 days
|
Need of medical treatment (topical, oral, intravenous) due to injury/allergy of skin around the vascular indwelling catheters
|
0-14 days
|
|
Vascular indwelling catheter removal
Time Frame: 0-14 days
|
Need of catheter removal due to injury/allergy of skin around
|
0-14 days
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Occurrence of skin injury/allergy
Time Frame: 0-14 days
|
Skin injury/allergy of the skin around the vascular indwelling catheter
|
0-14 days
|
|
Pain degree/severity of the skin
Time Frame: 0-14 days
|
Pain degree of the skin around the vascular indwelling catheter
|
0-14 days
|
|
Number of dressing changes
Time Frame: 0-14 days
|
Total number of dressing changes of the vascular indwelling catheter
|
0-14 days
|
|
Catheter-related bloodstream infection
Time Frame: 0-14 days
|
Occurrence of catheter-related bloodstream infection
|
0-14 days
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Principal Investigator: Hīng-Ka Lîm, MD, PhD, National Taiwan University Hospital Yunlin Branch
- Principal Investigator: Ching-Ching Yang, RN, National Taiwan University
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
January 1, 2024
Primary Completion (Actual)
December 31, 2024
Study Completion (Actual)
December 31, 2024
Study Registration Dates
First Submitted
December 20, 2023
First Submitted That Met QC Criteria
December 20, 2023
First Posted (Actual)
January 5, 2024
Study Record Updates
Last Update Posted (Actual)
March 25, 2025
Last Update Submitted That Met QC Criteria
January 17, 2025
Last Verified
December 1, 2024
More Information
Terms related to this study
Other Study ID Numbers
- 202310113DIND
- NTUHYL 113-X015 (Other Grant/Funding Number: National Taiwan University Hospital Yunlin Branch)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Skin Injury
-
Istanbul Medipol University HospitalMedipol University; Kartal Dr. Lütfi Kirdar City HospitalRecruitingPressure Injury | Skin Lesions | Skin InjuryTurkey (Türkiye)
-
Istanbul University - CerrahpasaThe Scientific and Technological Research Council of TurkeyCompleted
-
Marmara UniversityRecruiting
-
Wake Forest University Health SciencesCompleted
-
Owlet Baby Care, Inc.University of Utah; Louisiana State University Health Sciences Center Shreveport and other collaboratorsCompletedSkin InjuryUnited States
-
Masimo CorporationCompletedFalls Injury | Pressure Ulcer | Pressure InjuryUnited States
-
Ankara Yildirim Beyazıt UniversityAnkara City Hospital BilkentCompletedPressure Injury PreventionTurkey
-
Saglik Bilimleri UniversitesiEnrolling by invitationPressure Injury | Risk Assessment | Nursing Care | Pressure Injury PreventionTurkey (Türkiye)
-
Tepecik Training and Research HospitalNot yet recruitingPressure Injury | Medical Device Site Injury
-
MAİDE YEŞİLYURTCompletedMedical Device Site InjuryTurkey
Clinical Trials on Skin barrier film
-
Instituto Nacional de Cancer, BrazilRio de Janeiro State Research Supporting Foundation (FAPERJ)CompletedRadiodermatitis | Injury, RadiationBrazil
-
Solventum US LLC3MCompleted
-
Clinical Research Centre, MalaysiaTwin Catalyst Sdn. Bhd.Completed
-
Chang Gung Memorial HospitalConvaTect, TaiwanUnknownStoma Ileostomy | Stoma ColostomyTaiwan
-
Miller Biosciences LLCRecruiting
-
King Faisal Specialist Hospital & Research CenterNot yet recruitingHead and Neck Cancer
-
Charite University, Berlin, GermanyCompleted
-
Atteris Healthcare, LLCRochal Industries LLCTerminatedChronic WoundsUnited States
-
National Institute of Allergy and Infectious Diseases...Completed
-
Lund University HospitalRecruitingMycosis Fungoides | Sezary SyndromeSweden